Dehydrocrotonin and its derivative, dimethylamide-crotonin induce apoptosis with lipid peroxidation and activation of caspases-2, -6 and -9 in human leukemic cells HL60

Toxicology
Maristella Conte AnazettiMarcela Haun

Abstract

A variety of stimuli can induce cells to undergo apoptosis, with one of the most reproducible inducers being mild oxidative stress following exposure to anticancer agents. Apoptosis involves events mediated by cysteine proteases (caspases) that are classified as initiators (-8, -9 and -12) or executors (-2, -3, -6 and -7). In this study, we examined the mechanisms of apoptosis induced by dehydrocrotonin (DHC), a diterpene lactone isolated from the Amazonian plant Croton cajucara, and its synthetic derivative, dimethylamide-crotonin (DCR), in human HL60 promyelocytic leukemia cells. Flow cytometric analysis of HL60 cells after treatment for 72 h showed that DCR- and DHC-induced apoptosis, with maximum cell death at a concentration of 250 microM for both compounds. DCR and DHC were effective in triggering the activation of caspases-2, -6 and -9. The level of reduced glutathione (GSH) decreased, whereas there was an increase in thiobarbituric acid-reactive substance (TBARS) production and in mitochondrial swelling. These effects on mitochondrial swelling, GSH content and lipid peroxidation were abolished by cyclosporine A, an inhibitor of the membrane permeability transition. The cytotoxicity of DHC and DCR was prevented by a high...Continue Reading

References

Jan 1, 1991·International Review of Experimental Pathology·M J Arends, A H Wyllie
May 1, 1989·International Journal of Radiation Oncology, Biology, Physics·J B MitchellA Russo
Jan 1, 1980·International Review of Cytology·A H WyllieA R Currie
Dec 1, 1995·Toxicology Letters·A F SlaterS Orrenius
Sep 15, 1996·Archives of Biochemistry and Biophysics·M G Salgo, W A Pryor
Mar 3, 1997·FEBS Letters·A GormanT G Cotter
Jan 1, 1997·Advances in Pharmacology·P W MesnerS H Kaufmann
Aug 22, 1997·The Journal of Biological Chemistry·H LiJ Yuan
Aug 15, 1997·The Biochemical Journal·G M Cohen
Aug 28, 1998·Science·N A Thornberry, Y Lazebnik
Oct 24, 1998·Biochemistry and Molecular Biology International·M A TorsoniS H Ogo
Oct 20, 1999·Stem Cells·L G Israels, E D Israels
Mar 18, 2000·Toxicology Letters·K Debatin
Mar 31, 2000·Experimental Cell Research·S H Kaufmann, W C Earnshaw
Aug 10, 2000·Trends in Cell Biology·S Desagher, J C Martinou
Jan 6, 2001·Phytochemistry·J A BeutlerM R Boyd
Mar 12, 2002·Bioorganic & Medicinal Chemistry·Gholam Hossein HakimelahiShahram Hakimelahi
May 7, 2002·Toxicology Letters·Salmaan H Inayat-HussainNaoyuki Taniguchi
Jun 20, 2002·Journal of Immunological Methods·James F CurtinThomas G Cotter
Sep 11, 2002·Toxicology in Vitro : an International Journal Published in Association with BIBRA·D StevensonM H Grant
Dec 24, 2002·Japanese Journal of Cancer Research : Gann·Jung-Hye ChoiKyung-Tae Lee
Feb 5, 2003·Planta medica·Ana Claudia Galvão FreireCarmen Veríssima Ferreira
Jun 14, 2003·Leukemia Research·Ana Claudia Galvão FreireCarmen Veríssima Ferreira

❮ Previous
Next ❯

Citations

Apr 16, 2009·Journal of Pharmaceutical Sciences·Lucas FrungilloNelson Durán

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.